CA2537545A1 - Thienopyrroles as antiviral agents - Google Patents

Thienopyrroles as antiviral agents Download PDF

Info

Publication number
CA2537545A1
CA2537545A1 CA002537545A CA2537545A CA2537545A1 CA 2537545 A1 CA2537545 A1 CA 2537545A1 CA 002537545 A CA002537545 A CA 002537545A CA 2537545 A CA2537545 A CA 2537545A CA 2537545 A1 CA2537545 A1 CA 2537545A1
Authority
CA
Canada
Prior art keywords
thieno
cyclohexyl
pyrrole
methyl
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002537545A
Other languages
English (en)
French (fr)
Inventor
Barbara Attenni
Jose Ignacio Martin Hernando
Savina Malancona
Frank Narjes
Jesus Maria Ontoria Ontoria
Michael Rowley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2537545A1 publication Critical patent/CA2537545A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002537545A 2003-09-09 2004-09-07 Thienopyrroles as antiviral agents Abandoned CA2537545A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0321003.6 2003-09-09
GBGB0321003.6A GB0321003D0 (en) 2003-09-09 2003-09-09 Compounds, compositions and uses
PCT/GB2004/003838 WO2005023819A1 (en) 2003-09-09 2004-09-07 Thienopyrroles as antiviral agents

Publications (1)

Publication Number Publication Date
CA2537545A1 true CA2537545A1 (en) 2005-03-17

Family

ID=29226699

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002537545A Abandoned CA2537545A1 (en) 2003-09-09 2004-09-07 Thienopyrroles as antiviral agents

Country Status (11)

Country Link
US (1) US7781431B2 (enExample)
EP (1) EP1664059B1 (enExample)
JP (1) JP2007505091A (enExample)
CN (1) CN1849323A (enExample)
AT (1) ATE373005T1 (enExample)
AU (1) AU2004270470A1 (enExample)
CA (1) CA2537545A1 (enExample)
DE (1) DE602004008945T2 (enExample)
ES (1) ES2291933T3 (enExample)
GB (1) GB0321003D0 (enExample)
WO (1) WO2005023819A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0413234A (pt) 2003-08-01 2006-10-03 Genelabs Tech Inc derivados de imidazola bicìclica contra flaviviridae
WO2005049622A1 (ja) * 2003-11-19 2005-06-02 Japan Tobacco Inc. ５－５員縮合複素環化合物及びそのｈｃｖポリメラーゼ阻害剤としての用途
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
GB0416396D0 (en) * 2004-07-22 2004-08-25 Angeletti P Ist Richerche Bio Therapeutic agents
US7659263B2 (en) * 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
AU2006242475B2 (en) 2005-05-02 2011-07-07 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
GB0509326D0 (en) 2005-05-09 2005-06-15 Angeletti P Ist Richerche Bio Therapeutic compounds
US8278322B2 (en) 2005-08-01 2012-10-02 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
GB0609492D0 (en) 2006-05-15 2006-06-21 Angeletti P Ist Richerche Bio Therapeutic agents
GB0612423D0 (en) 2006-06-23 2006-08-02 Angeletti P Ist Richerche Bio Therapeutic agents
CN101583372A (zh) 2006-10-24 2009-11-18 默克公司 Hcv ns3蛋白酶抑制剂
US8138164B2 (en) 2006-10-24 2012-03-20 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
CA2667165A1 (en) 2006-10-24 2008-05-02 Merck & Co., Inc. Hcv ns3 protease inhibitors
WO2008057208A2 (en) 2006-10-27 2008-05-15 Merck & Co., Inc. Hcv ns3 protease inhibitors
JP5268927B2 (ja) 2006-10-27 2013-08-21 メルク・シャープ・アンド・ドーム・コーポレーション Ｈｃｖｎｓ３プロテアーゼ阻害剤
GB0625349D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
GB0625345D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
US8101595B2 (en) 2006-12-20 2012-01-24 Istituto di Ricerche di Biologia Molecolare P. Angletti SpA Antiviral indoles
AU2008277442A1 (en) 2007-07-17 2009-01-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Macrocyclic indole derivatives for the treatment of hepatitis C infections
CN101754974B (zh) 2007-07-19 2016-02-03 Msd意大利有限公司 作为抗病毒剂的大环化合物
EP2234977A4 (en) 2007-12-19 2011-04-13 Boehringer Ingelheim Int VIRAL POLYMERASE INHIBITORS
CN102014911A (zh) 2008-04-28 2011-04-13 默沙东公司 Hcv ns3蛋白酶抑制剂
US8126839B2 (en) * 2008-06-19 2012-02-28 Yahoo! Inc. Methods and apparatuses for adapting a ranking function of a search engine for use with a specific domain
ES2392611T3 (es) 2008-07-22 2012-12-12 Merck Sharp & Dohme Corp. Compuestos de quinoxalina macrocíclica como inhibidores de la proteasa NS3 del VHC
KR20110116136A (ko) 2009-01-07 2011-10-25 싸이넥시스, 인크. Ｈｃｖ 및 ｈｉｖ 감염의 치료에 사용하기 위한 사이클로스포린 유도체
US8828930B2 (en) 2009-07-30 2014-09-09 Merck Sharp & Dohme Corp. Hepatitis C virus NS3 protease inhibitors
TW201130852A (en) * 2009-12-23 2011-09-16 Abbott Lab Novel thienopyrrole compounds
CN105399697A (zh) * 2014-09-12 2016-03-16 苏州旺山旺水生物医药有限公司 一种氨基磺酰基类化合物、其制备方法及用途
EP3246330A1 (en) * 2016-05-18 2017-11-22 Istituto Europeo di Oncologia S.r.l. Imidazoles as histone demethylase inhibitors
TWI811428B (zh) 2018-08-21 2023-08-11 日商杏林製藥股份有限公司 雙環雜芳香環衍生物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3706810A (en) * 1970-09-15 1972-12-19 American Cyanamid Co N-morpholinoalkyl-thieno(3,2-b)pyrrole-5-carboxamides
SU367098A1 (ru) * 1971-01-20 1973-01-23 Способ получения производных 4,5-диоксотиено- -
SU478833A1 (ru) * 1972-12-29 1975-07-30 Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Им.С.Орджоникидзе Способ получени производных тиено -(3,2-в)-пиррола
JPH04356029A (ja) 1990-07-02 1992-12-09 Japan Synthetic Rubber Co Ltd 非線形光学素子
JPH04179949A (ja) * 1990-11-15 1992-06-26 Fuji Photo Film Co Ltd 新規な色素形成カプラーおよび該カプラーを用いたハロゲン化銀カラー写真感光材料
US5340833A (en) * 1992-05-01 1994-08-23 Eisai Co., Ltd. Urokinase inhibitors
CZ20013424A3 (cs) 1999-12-27 2002-02-13 Japan Tobacco Inc. Sloučeniny s fúzovanými kruhy a jejich pouľití jako léčiva
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
JP2003212846A (ja) * 2001-06-26 2003-07-30 Japan Tobacco Inc 縮合環化合物及びｃ型肝炎治療剤
AR035543A1 (es) 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
CA2448737C (en) 2001-07-20 2010-06-01 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US20030134853A1 (en) 2001-09-26 2003-07-17 Priestley Eldon Scott Compounds useful for treating hepatitis C virus
GB0222909D0 (en) * 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
CA2522225A1 (en) * 2003-04-17 2004-10-28 Pfizer Products Inc. Carboxamide derivatives as anti-diabetic agents

Also Published As

Publication number Publication date
WO2005023819A1 (en) 2005-03-17
WO2005023819A9 (en) 2006-03-23
GB0321003D0 (en) 2003-10-08
DE602004008945T2 (de) 2008-05-29
US7781431B2 (en) 2010-08-24
CN1849323A (zh) 2006-10-18
JP2007505091A (ja) 2007-03-08
ES2291933T3 (es) 2008-03-01
AU2004270470A1 (en) 2005-03-17
DE602004008945D1 (en) 2007-10-25
EP1664059A1 (en) 2006-06-07
ATE373005T1 (de) 2007-09-15
US20090036443A1 (en) 2009-02-05
EP1664059B1 (en) 2007-09-12

Similar Documents

Publication Publication Date Title
EP1664059B1 (en) Thienopyrroles as antiviral agents
AU2004280120A1 (en) Indoles and azaindoles as antiviral agents
US7973026B2 (en) Thienopyrroles as antiviral agents
AU2022202524B2 (en) Compounds, compositions and methods
EP3080116A1 (en) Pyrazolopyridine derivatives as modulators of tnf activity
CA2520896A1 (en) Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
AU3036000A (en) Compounds
KR20060127127A (ko) Ｃｈｋ １ 억제제로서 티오펜 유도체
US5721245A (en) 4- 3-indolyl!-1H-pyrrolone
AU668206B2 (en) 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
JP2016539974A (ja) Ｔｎｆ活性のモジュレーターとしてのイミダゾトリアジン誘導体
US6080745A (en) Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
TW200806677A (en) Thiazolyl-dihydro-indazole
CA2335106A1 (en) Thienodipyridine derivatives, production and use thereof
JP5159630B2 (ja) 縮環複素環誘導体
NZ540768A (en) Benzamide derivatives as oxytocin agonists and vasopressin antagonists
US3849405A (en) Thieno-(2,3-e)(1,4)diazepin-2-ones
US3950526A (en) Quinazoline derivatives in pharmaceutical compositions for treating pain and inflammation
JPS62289582A (ja) 置換チアシクロアルケノ〔３，２−ｂ〕ピリジン類
US6166034A (en) Spiro piperidine derivatives as 5HT1D receptor antagonists
US3965111A (en) Triazolothienodiazepine compounds
IE893871L (en) New indole derivatives, process for preparing them and¹pharmaceutical compositions containing them
WO1981000568A1 (fr) Benzodiazepinones, leur procede de preparation, leur utilisation
PL93698B1 (enExample)
HK1080737B (en) Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses

Legal Events

Date Code Title Description
FZDE Discontinued